Pfizer PFE Other Segment Items

Segments

Biopharma$116M+48.7%

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Market cap$143.68B+11.1%

Enterprise value$206.35B+9.2%

P/E11.9×—

P/S2.3×+0.2×

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×